Tervishoiuteenuste osutamisel kasutatavate ravimite ostmine
Contracts total
34 036 925 €
Bids
2
Type
Supplies
Published
08.04.2025
Tender description
Käesoleva hanke eesmärk on sõlmida raamleping tervishoiuteenuste osutamisel kasutatavate ravimite ostmiseks Lisas 1 toodud nimetuste ja kirjelduste alusel.
Awarded contracts
02.07.2025| Lot | Tenderer | Amount | Bids | Awarded |
|---|---|---|---|---|
| B03AC01/ B03AC80 Pikatoimeline rauapreparaat | TAMRO EESTI OÜ | 438 724 € | 2 | 27.06.2025 |
| B03AC83 /B03AC06 Lühitoimeline rauapreparaat | TAMRO EESTI OÜ | 6630 € | 2 | 27.06.2025 |
| B06AC05 Lanadelumab | MAGNUM MEDICAL OÜ | 2 472 378 € | 1 | 01.07.2025 |
| L01FF02 Pembrolizumabum | MAGNUM MEDICAL OÜ | 4 670 588 € | 1 | 01.07.2025 |
| L01FF01 Nivolumab | TAMRO EESTI OÜ | 17 034 089 € | 1 | 27.06.2025 |
| L01FA03 Obinutuzumab | Roche Eesti Osaühing | 176 852 € | 1 | 01.07.2025 |
| L01XY01 Tsütarabiin+doksürubitsiin liposomaalne | MAGNUM MEDICAL OÜ | 938 665 € | 1 | 01.07.2025 |
| J05AX10 Maribaviir | MAGNUM MEDICAL OÜ | 274 185 € | 1 | 01.07.2025 |
| J06BB16 Palivizumab | MAGNUM MEDICAL OÜ | 82 853 € | 1 | 01.07.2025 |
| J06BB16 Palivizumab | MAGNUM MEDICAL OÜ | 235 495 € | 1 | 01.07.2025 |
| L04AC02 Basiliximab | MAGNUM MEDICAL OÜ | 300 557 € | 2 | 01.07.2025 |
| L04AC14 Sarilumab | MAGNUM MEDICAL OÜ | 358 281 € | 1 | 01.07.2025 |
| L01FX04 Ipilimumab | TAMRO EESTI OÜ | 934 827 € | 1 | 27.06.2025 |
| L01XC24 Daratumumab | MAGNUM MEDICAL OÜ | 4 278 853 € | 2 | 01.07.2025 |
| L01XC19 Blinatumomab | MAGNUM MEDICAL OÜ | 8539 € | 2 | 01.07.2025 |
| L01XE02 Gefitinib | Apteegikaubanduse Hulgimüük OÜ | 40 516 € | 1 | 30.06.2025 |
| M05BX05 Burosumab | TAMRO EESTI OÜ | 1 322 021 € | 1 | 27.06.2025 |
| M05BX05 Burosumab | TAMRO EESTI OÜ | 440 812 € | 1 | 27.06.2025 |
| M05BX05 Burosumab | TAMRO EESTI OÜ | 22 061 € | 1 | 27.06.2025 |
Tender lots
22| Lot | Estimated value | Deadline |
|---|---|---|
| B03AC01/ B03AC80 Pikatoimeline rauapreparaat | 13.05.2025 | |
| B03AC83 /B03AC06 Lühitoimeline rauapreparaat | 13.05.2025 | |
| B06AC05 Lanadelumab | 13.05.2025 | |
| L01FF02 Pembrolizumabum | 13.05.2025 | |
| L01FF01 Nivolumab | 13.05.2025 | |
| L01FA03 Obinutuzumab | 13.05.2025 | |
| L01XY01 Tsütarabiin+doksürubitsiin liposomaalne | 13.05.2025 | |
| J05AX10 Maribaviir | 13.05.2025 | |
| J06BB16 Palivizumab | 13.05.2025 | |
| J06BB16 Palivizumab | 13.05.2025 | |
| L04AC02 Basiliximab | 13.05.2025 | |
| L04AC14 Sarilumab | 13.05.2025 | |
| L01FX04 Ipilimumab | 13.05.2025 | |
| L01XC24 Daratumumab | 13.05.2025 | |
| L01XC19 Blinatumomab | 13.05.2025 | |
| L01XE02 Gefitinib | 13.05.2025 | |
| L01XY02 Pertuzumab +trastuzumab | 13.05.2025 | |
| L01XY02 Pertuzumab + trastuzumab | 13.05.2025 | |
| L04AA26 Belimumab | 13.05.2025 | |
| M05BX05 Burosumab | 13.05.2025 | |
| M05BX05 Burosumab | 13.05.2025 | |
| M05BX05 Burosumab | 13.05.2025 |
Similar open tenders
- Parenteraalsed toitelahusedOpen for bidsDeadline 20.10.2026 2 daysEstimated value 400 000 €Published 18.09.2026
- KlesrovimabOpen for bidsDeadline 20.10.2026 2 daysEstimated value 190 000 €Published 05.10.2026
- Puhasruumide desinfektsiooni- ja puhastusvahendidOpen for bidsDeadline 21.10.2026 3 daysPublished 17.09.2026
- Urogenitaalsüsteemi ravimid ja hormoonravimidOpen for bidsDeadline 23.10.2026 5 daysPublished 18.09.2026
- Ravim B01AB05 EnoksapariinOpen for bidsDeadline 27.10.2026 9 daysPublished 21.09.2026
- Kemoteraapias kasutatavad ravimidOpen for bidsDeadline 27.10.2026 9 daysPublished 22.09.2026
Source: Public Procurement Register open data. Amounts exclude VAT. The notice published in the Public Procurement Register is binding.